Catalyst Wire Dossier Catalyst Wire Dossier

PYQUVI

deflazacort · Aucta Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PYQUVI, covering 2025-06-30 to 2025-06-30. Get the full timeline:

Most recent: FDA Approved: PYQUVI — Original Application (Aucta Pharmaceuticals, Inc.)

See pricing